# Abeona Therapeutics Q3 2026 Earnings Call

> Abeona Therapeutics reports Q3 2026 earnings with acquisition of APT-1011.
- Title: Abeona Therapeutics Q3 2026 Earnings Call · Seekingalpha
- Summary: Abeona Therapeutics reports Q3 2026 earnings with acquisition of APT-1011. Abeona Therapeutics acquired APT-1011 in Q3 2026 as part of its financial results.
- Keywords: abeona therapeutics, q3 2026, apt-1011, earnings call, investor relations, corporate communications, Seekingalpha
- Source: Seekingalpha — https://seekingalpha.com/article/4965079-abeona-therapeutics-inc-abeo-q3-2026-earnings-call-transcript
- Published: 2026-11-09T20:31:30+00:00
- Read time: 1 min
- Topics: abeona therapeutics, q3 2026, apt-1011, earnings call, investor relations, corporate communications, money, business
## Earnings Call Announcement
Abeona Therapeutics held Q3 2026 earnings call on November 9, 2026.
## Acquisition of APT-1011
Company announced acquisition of APT-1011 as part of Q3 2026 financial results.
## Leadership Present
Gregory Gin, Vishwas Seshadri, Madhav Vasanthavada, and Joseph Vazzano participated in call.
## Key takeaway

Abeona Therapeutics acquired APT-1011 in Q3 2026 as part of its financial results.